Examination of factors contributing to the prognosis in TACE treatment of hepatocellular carcinoma
The goal of this study is to identify preoperative factors that influence prognosis in TACE of hepatocellular carcinoma (HCC). Between April 2014 and April 2021, 106 consecutive patients underwent TACE for HCC. We discovered that albumin, ALBI score, AFP, tumor number, and Up-to-7 were useful factor...
Gespeichert in:
| Veröffentlicht in: | Kanzo 2022/04/01, Vol.63(4), pp.187-195 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng ; jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 195 |
|---|---|
| container_issue | 4 |
| container_start_page | 187 |
| container_title | Kanzo |
| container_volume | 63 |
| creator | Yasui, Toshimitsu Adachi, Yujiro Satake, Shin Aoi, Kenji Jou, Hisashi Kakita, Naruyasu Yamada, Yukinori Tabuchi, Takahiro Katayama, Kazuhiro |
| description | The goal of this study is to identify preoperative factors that influence prognosis in TACE of hepatocellular carcinoma (HCC). Between April 2014 and April 2021, 106 consecutive patients underwent TACE for HCC. We discovered that albumin, ALBI score, AFP, tumor number, and Up-to-7 were useful factors in univariate analysis; albumin (p = 0.025), AFP (p = 0.000), and tumor number (p = 0.000) were useful factors in multivariate analysis. We compared the relationship between two tumor factors (tumor number and tumor diameter) and selective embolization. The AUC of tumor number was 0.754 and that of tumor diameter was 0.693, with tumor number being higher. It has been proposed that tumor number, rather than tumor diameter, is a better predictor of TACE prognosis. It is considered to be one of the reasons why tumor number has a stronger effect on selective TACE. |
| doi_str_mv | 10.2957/kanzo.63.187 |
| format | Article |
| fullrecord | <record><control><sourceid>jstage_cross</sourceid><recordid>TN_cdi_crossref_primary_10_2957_kanzo_63_187</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>article_kanzo_63_4_63_187_article_char_en</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2017-2bef95de729d8751a2e245dd3a8319e17d78c0af64c019eca280d4c706f42d353</originalsourceid><addsrcrecordid>eNpFkM1KAzEUhYMoWGp3PkAewKn5nUxWUkq1QsFNXQ93Mpk2OpOUJAX16W1tqavL4X7nLD6E7imZMi3V4yf4nzAt-ZRW6gqNaFXRgkvNr9GICEkLwQi_RZOUXEMIKxXRmo1Qs_iCwXnILngcOtyBySEmbILP0TX77PwG54Dz1uJdDBsfkkvYebyezRc4Rwt5sD4fq1u7gxyM7ft9DxEbiMb5MMAduumgT3ZyvmP0_rxYz5fF6u3ldT5bFYYRqgrW2E7L1iqm20pJCswyIduWQ8WptlS1qjIEulIYcsgGWEVaYRQpO8FaLvkYPZx2TQwpRdvVu-gGiN81JfVRUf2nqC55fVB0wJ9O-EfKsLEXGGJ2prf_sDg3Lh-zhVhbz38B821zqg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Examination of factors contributing to the prognosis in TACE treatment of hepatocellular carcinoma</title><source>J-STAGE Free</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Yasui, Toshimitsu ; Adachi, Yujiro ; Satake, Shin ; Aoi, Kenji ; Jou, Hisashi ; Kakita, Naruyasu ; Yamada, Yukinori ; Tabuchi, Takahiro ; Katayama, Kazuhiro</creator><creatorcontrib>Yasui, Toshimitsu ; Adachi, Yujiro ; Satake, Shin ; Aoi, Kenji ; Jou, Hisashi ; Kakita, Naruyasu ; Yamada, Yukinori ; Tabuchi, Takahiro ; Katayama, Kazuhiro</creatorcontrib><description>The goal of this study is to identify preoperative factors that influence prognosis in TACE of hepatocellular carcinoma (HCC). Between April 2014 and April 2021, 106 consecutive patients underwent TACE for HCC. We discovered that albumin, ALBI score, AFP, tumor number, and Up-to-7 were useful factors in univariate analysis; albumin (p = 0.025), AFP (p = 0.000), and tumor number (p = 0.000) were useful factors in multivariate analysis. We compared the relationship between two tumor factors (tumor number and tumor diameter) and selective embolization. The AUC of tumor number was 0.754 and that of tumor diameter was 0.693, with tumor number being higher. It has been proposed that tumor number, rather than tumor diameter, is a better predictor of TACE prognosis. It is considered to be one of the reasons why tumor number has a stronger effect on selective TACE.</description><identifier>ISSN: 0451-4203</identifier><identifier>EISSN: 1881-3593</identifier><identifier>DOI: 10.2957/kanzo.63.187</identifier><language>eng ; jpn</language><publisher>The Japan Society of Hepatology</publisher><subject>HCC ; intermediate stage ; systemic chemotherapy ; TACE refractoriness ; tumor number</subject><ispartof>Kanzo, 2022/04/01, Vol.63(4), pp.187-195</ispartof><rights>2022 The Japan Society of Hepatology</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2017-2bef95de729d8751a2e245dd3a8319e17d78c0af64c019eca280d4c706f42d353</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,1883,27924,27925</link.rule.ids></links><search><creatorcontrib>Yasui, Toshimitsu</creatorcontrib><creatorcontrib>Adachi, Yujiro</creatorcontrib><creatorcontrib>Satake, Shin</creatorcontrib><creatorcontrib>Aoi, Kenji</creatorcontrib><creatorcontrib>Jou, Hisashi</creatorcontrib><creatorcontrib>Kakita, Naruyasu</creatorcontrib><creatorcontrib>Yamada, Yukinori</creatorcontrib><creatorcontrib>Tabuchi, Takahiro</creatorcontrib><creatorcontrib>Katayama, Kazuhiro</creatorcontrib><title>Examination of factors contributing to the prognosis in TACE treatment of hepatocellular carcinoma</title><title>Kanzo</title><addtitle>Kanzo</addtitle><description>The goal of this study is to identify preoperative factors that influence prognosis in TACE of hepatocellular carcinoma (HCC). Between April 2014 and April 2021, 106 consecutive patients underwent TACE for HCC. We discovered that albumin, ALBI score, AFP, tumor number, and Up-to-7 were useful factors in univariate analysis; albumin (p = 0.025), AFP (p = 0.000), and tumor number (p = 0.000) were useful factors in multivariate analysis. We compared the relationship between two tumor factors (tumor number and tumor diameter) and selective embolization. The AUC of tumor number was 0.754 and that of tumor diameter was 0.693, with tumor number being higher. It has been proposed that tumor number, rather than tumor diameter, is a better predictor of TACE prognosis. It is considered to be one of the reasons why tumor number has a stronger effect on selective TACE.</description><subject>HCC</subject><subject>intermediate stage</subject><subject>systemic chemotherapy</subject><subject>TACE refractoriness</subject><subject>tumor number</subject><issn>0451-4203</issn><issn>1881-3593</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpFkM1KAzEUhYMoWGp3PkAewKn5nUxWUkq1QsFNXQ93Mpk2OpOUJAX16W1tqavL4X7nLD6E7imZMi3V4yf4nzAt-ZRW6gqNaFXRgkvNr9GICEkLwQi_RZOUXEMIKxXRmo1Qs_iCwXnILngcOtyBySEmbILP0TX77PwG54Dz1uJdDBsfkkvYebyezRc4Rwt5sD4fq1u7gxyM7ft9DxEbiMb5MMAduumgT3ZyvmP0_rxYz5fF6u3ldT5bFYYRqgrW2E7L1iqm20pJCswyIduWQ8WptlS1qjIEulIYcsgGWEVaYRQpO8FaLvkYPZx2TQwpRdvVu-gGiN81JfVRUf2nqC55fVB0wJ9O-EfKsLEXGGJ2prf_sDg3Lh-zhVhbz38B821zqg</recordid><startdate>20220401</startdate><enddate>20220401</enddate><creator>Yasui, Toshimitsu</creator><creator>Adachi, Yujiro</creator><creator>Satake, Shin</creator><creator>Aoi, Kenji</creator><creator>Jou, Hisashi</creator><creator>Kakita, Naruyasu</creator><creator>Yamada, Yukinori</creator><creator>Tabuchi, Takahiro</creator><creator>Katayama, Kazuhiro</creator><general>The Japan Society of Hepatology</general><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20220401</creationdate><title>Examination of factors contributing to the prognosis in TACE treatment of hepatocellular carcinoma</title><author>Yasui, Toshimitsu ; Adachi, Yujiro ; Satake, Shin ; Aoi, Kenji ; Jou, Hisashi ; Kakita, Naruyasu ; Yamada, Yukinori ; Tabuchi, Takahiro ; Katayama, Kazuhiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2017-2bef95de729d8751a2e245dd3a8319e17d78c0af64c019eca280d4c706f42d353</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; jpn</language><creationdate>2022</creationdate><topic>HCC</topic><topic>intermediate stage</topic><topic>systemic chemotherapy</topic><topic>TACE refractoriness</topic><topic>tumor number</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yasui, Toshimitsu</creatorcontrib><creatorcontrib>Adachi, Yujiro</creatorcontrib><creatorcontrib>Satake, Shin</creatorcontrib><creatorcontrib>Aoi, Kenji</creatorcontrib><creatorcontrib>Jou, Hisashi</creatorcontrib><creatorcontrib>Kakita, Naruyasu</creatorcontrib><creatorcontrib>Yamada, Yukinori</creatorcontrib><creatorcontrib>Tabuchi, Takahiro</creatorcontrib><creatorcontrib>Katayama, Kazuhiro</creatorcontrib><collection>CrossRef</collection><jtitle>Kanzo</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yasui, Toshimitsu</au><au>Adachi, Yujiro</au><au>Satake, Shin</au><au>Aoi, Kenji</au><au>Jou, Hisashi</au><au>Kakita, Naruyasu</au><au>Yamada, Yukinori</au><au>Tabuchi, Takahiro</au><au>Katayama, Kazuhiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Examination of factors contributing to the prognosis in TACE treatment of hepatocellular carcinoma</atitle><jtitle>Kanzo</jtitle><addtitle>Kanzo</addtitle><date>2022-04-01</date><risdate>2022</risdate><volume>63</volume><issue>4</issue><spage>187</spage><epage>195</epage><pages>187-195</pages><issn>0451-4203</issn><eissn>1881-3593</eissn><abstract>The goal of this study is to identify preoperative factors that influence prognosis in TACE of hepatocellular carcinoma (HCC). Between April 2014 and April 2021, 106 consecutive patients underwent TACE for HCC. We discovered that albumin, ALBI score, AFP, tumor number, and Up-to-7 were useful factors in univariate analysis; albumin (p = 0.025), AFP (p = 0.000), and tumor number (p = 0.000) were useful factors in multivariate analysis. We compared the relationship between two tumor factors (tumor number and tumor diameter) and selective embolization. The AUC of tumor number was 0.754 and that of tumor diameter was 0.693, with tumor number being higher. It has been proposed that tumor number, rather than tumor diameter, is a better predictor of TACE prognosis. It is considered to be one of the reasons why tumor number has a stronger effect on selective TACE.</abstract><pub>The Japan Society of Hepatology</pub><doi>10.2957/kanzo.63.187</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0451-4203 |
| ispartof | Kanzo, 2022/04/01, Vol.63(4), pp.187-195 |
| issn | 0451-4203 1881-3593 |
| language | eng ; jpn |
| recordid | cdi_crossref_primary_10_2957_kanzo_63_187 |
| source | J-STAGE Free; EZB-FREE-00999 freely available EZB journals |
| subjects | HCC intermediate stage systemic chemotherapy TACE refractoriness tumor number |
| title | Examination of factors contributing to the prognosis in TACE treatment of hepatocellular carcinoma |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T03%3A27%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstage_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Examination%20of%20factors%20contributing%20to%20the%20prognosis%20in%20TACE%20treatment%20of%20hepatocellular%20carcinoma&rft.jtitle=Kanzo&rft.au=Yasui,%20Toshimitsu&rft.date=2022-04-01&rft.volume=63&rft.issue=4&rft.spage=187&rft.epage=195&rft.pages=187-195&rft.issn=0451-4203&rft.eissn=1881-3593&rft_id=info:doi/10.2957/kanzo.63.187&rft_dat=%3Cjstage_cross%3Earticle_kanzo_63_4_63_187_article_char_en%3C/jstage_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |